113294-82-9

Basic information

• Product Name: angiopeptin
• Synonyms: 3-(2-Naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-L-threoninamide;3-(2-Naphthyl)alanyl-cystinyl-tyrosyl-tryptophyl-lysyl-valyl-cystinyl-threonine amide;3-(2-Naphthyl)-D-Ala-Cys-Tyr-D-Trp-Lys-Val-Cys-Thr-nh2;D-Nal-Cys-Tyr-Trp-Lys-Val-Cys-Thr-nh2;L-Threoninamide, 3-(2-naphthalenyl)-D-alanyl-L-cysteinyl-L-tyrosyl-D-tryptophyl-L-lysyl-L-valyl-L-cysteinyl-;(S)-6-amino-2-((R)-2-((S)-2-((R)-2-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-3-mercaptopropanamido)-3-(4-hydroxyphenyl)propanamido)-3-(1H-indol-3-yl)propanamido)-N-((S)-1-(((R)-1-(((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide(WXG02269);(S)-6-amino-2-((R)-2-((S)-2-((R)-2-((R)-2-amino-3-(naphthalen-2-yl)propanamido)-3-mercaptopropanamido)-3-(4-hydroxyphenyl)propanamido)-3-(1H-indol-3-yl)propanamido)-N-((S)-1-(((R)-1-(((2S,3R)-1-amino-3-hydroxy-1-oxobutan-2-yl)amino)-3-mercapto-1-oxopropan-2-yl)amino)-3-methyl-1-oxobutan-2-yl)hexanamide
• CAS NO: 113294-82-9
• Molecular Formula: C54H71N11O10S2
• Molecular Weight: 1098.33924
• Mol File: 113294-82-9.mol
• Article Data: 0

Chemical Properties

• Boiling Point: 1502.5°Cat760mmHg
• Flash Point: 862.5°C
• Appearance: /
• Density: 1.324g/cm³
• Vapor Pressure: 0mmHg at 25°C
• Refractive Index: 1.641
• PKA: 9.16±0.10(Predicted)
• CAS DataBase Reference: angiopeptin(CAS DataBase Reference)
• NIST Chemistry Reference: angiopeptin(113294-82-9)
• EPA Substance Registry System: angiopeptin(113294-82-9)

Safety Data

• Hazardous Substances Data: 113294-82-9(Hazardous Substances Data)

Usage

Uses

Linear Lanreotide is an impurity of Lanreotide (CAS 108736-35-2) which can be used in biological study of computational approach to structural alerts in relation to furans, phenols, nitroaromatics, and thiophenes.

InChI:InChI=1/C54H71N11O10S2/c1-3-10-40(49(70)64-45(29-77)54(75)65-46(30(2)66)47(57)68)59-50(71)41(15-8-9-22-55)60-52(73)43(26-35-27-58-39-14-7-6-13-37(35)39)62-51(72)42(25-31-17-20-36(67)21-18-31)61-53(74)44(28-76)63-48(69)38(56)24-32-16-19-33-11-4-5-12-34(33)23-32/h4-7,11-14,16-21,23,27,30,38,40-46,58,66-67,76-77H,3,8-10,15,22,24-26,28-29,55-56H2,1-2H3,(H2,57,68)(H,59,71)(H,60,73)(H,61,74)(H,62,72)(H,63,69)(H,64,70)(H,65,75)/t30-,38-,40+,41+,42+,43-,44+,45+,46+/m1/s1

Related news

Allograft vasculopathyShort-term angiopeptin (cas 113294-82-9) therapy and the incidence of graft vessel disease after heart transplantation08/17/2019

BackgroundGraft vessel disease, the major limitation for long-term success after heart transplantation, is triggered by injury to the graft vessel endothelium, resulting in the expression of adhesion molecules, the migration of leukocytes into the graft, and the release of growth factors. Angiop...detailed

Early inhibition of myointimal proliferation by angiopeptin (cas 113294-82-9) after balloon catheter injury in the rabbit☆☆☆★08/15/2019

Purpose: Coronary artery restenosis after percutaneous transluminal angioplasty occurs in more than 40% of patients. Angiopeptin, a stable synthetic octapeptide analogue of somatostatin, attenuates accelerated coronary artery myointimal thickening in rabbit cardiac allografts and myointimal thic...detailed

Research paperInhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin (cas 113294-82-9) and BIM 23034☆08/13/2019

Proliferation of vascular smooth muscle is an early and major event in the formation of an atherosclerotic lesion. Here we report for the first time the inhibitory effects on myointimal proliferation of the rat carotid artery by a synthetic peptide, angiopeptin, and its closely related congener,...detailed